Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Breast Cancer

News digest – Frozen needles, a smokefree UK, microbubbles and… breaking cancer’s ‘legs’?

Frozen needles, a smokefree UK, microbubbles and how scientists in the US are trying to break cancer cells’ ‘legs’. Here’s our weekly news report.

Study estimates breast and ovarian cancer risk linked to faulty BRCA genes

A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

Breast cancer drug approved for NHS England

The drug trastuzumab emtansine (Kadcyla) will soon be routinely available for patients in England with an advanced type of breast cancer.

Combining immunotherapies could benefit some aggressive breast cancers

Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.

New chemotherapy approach offers breast cancer patients a better quality of life

The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF

Ovarian cancer drug reduces chance certain advanced breast cancers will get worse

A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.

Alcohol and breast cancer – how big is the risk?

A new report on breast cancer risk has made the headlines - but what does the evidence say?

Preventing unnecessary breast cancer treatment

This entry is part 15 of 15 in the series Grand ChallengeEvery year, around 6,300 women in the UK are told they have a condition called ductal carcinoma in situ (DCIS). In...

Taking a potential new breast cancer treatment from the lab to the clinic

Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer.

Pages